AmCAD-UT

AmCAD-UO

AmCAD-UT, the first AI CAD system for thyroid cancer detection, has been approved by FDA, CE, TFDA and other regulatory bodies. It's compatible with all commercial ultrasound 2B image systems. The software provides TI-RADS-based reports and uses AI deep learning to help physicians quickly analyze thyroid lesions, useful for Endocrinology, Radiology, ENT departments and health checkup centers.

AmCAD-UO holds the distinction of being the first CE marked/FDA 510K approved solution for awake patient examinations of the upper airway to detect Obstructive Sleep Apnea (OSA). Utilizing a combination of laser-guided positioning, automated scanning and an ultrasound device, AmCAD-UO system can accurately map the upper airway images and tissue characteristics. The system promotes consistency by standardizing ultrasound transducer scanning, thus mitigating variations reliant on the operator. This enables doctors to expedite the evaluation of OSA causes in just 10 minutes and provides a quantitative visual assessment for patients with moderate to severe OSA.